Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08FUK
|
||||
Former ID |
DNC011050
|
||||
Drug Name |
(R,S)-1-(5-methyl-1H-indol-1-yl)propan-2-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551219] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H16N2
|
||||
Canonical SMILES |
CC1=CC2=C(C=C1)N(C=C2)CC(C)N
|
||||
InChI |
1S/C12H16N2/c1-9-3-4-12-11(7-9)5-6-14(12)8-10(2)13/h3-7,10H,8,13H2,1-2H3
|
||||
InChIKey |
WETMFNBRIOBNTK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [551219] | |
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [551219] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.